MedPath

Valve Plane Tracking for TAVI; Automatic Valve plane tracking for Transcatheter Aortic Valve Implantation.

Withdrawn
Conditions
Aortic stenosis
Aorticvalve stenosis
10046973
Registration Number
NL-OMON40644
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1. Subject is * 18 years of age.
2. Subject is eligible for TAVI with a a CE approved transcatheter heart valve.
3. Subject understands the study requirements and the treatment procedures, and provides written informed consent.
4. Subject is capable of returning to the study hospital for all required follow-up.

Exclusion Criteria

1. The aortic root cannot be defined by the software.
2. Subject did not receive a valve because of aborted procedure.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Volume of contrast.<br /><br>- Valve deployment time.<br /><br>- Depth of implantation of the valve (non-coronary and left aortic sinus) in mm<br /><br>based upon contrast angiography after valve deployment.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Mortality within the hospital or at 30 days whichever comes first.<br /><br>- Renal insufficiency.<br /><br>- Paravalvular aortic regurgitation.</p><br>
© Copyright 2025. All Rights Reserved by MedPath